The treatment of recurrent central serous chorioretinopathy with intravitreal bevacizumab

Journal of Ocular Pharmacology and Therapeutics

Volumn 27, Issue 6, 2011, Pages 611-614

  Lee, Shelly T ^a   Adelman, Ron A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; BLURRED VISION; CASE REPORT; CENTRAL MACULAR THICKNESS; CENTRAL SEROUS RETINOPATHY; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; RECURRENT DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETROSPECTIVE STUDY; SUBRETINAL FLUID; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; CENTRAL SEROUS CHORIORETINOPATHY; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 83455203665     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0045     Document Type: Article

References (18)

1. Yannuzzi, L.A. Type-A behavior and central serous chorioretinopathy. Retina 7:111-130, 1987.
2. Carvalho-Recchia, C.A., Yannuzzi, L.A., Negrao, S., et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 109:1834-1837, 2002.
3. Gass J.D.M. Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central serous choroidopathy. Am. J. Ophthalmol. 63:587-615, 1967.
4. Klein, M.L., Van Buskirk, E.M., Friedman, E., Gragoudas, E., and Chandra, S. Experience with nontreatment of central serous choroidopathy. Arch. Ophthalmol. 91:247-250, 1974.
5. Piccolino, F.C., Eandi, C.M., Ventre, L., Rigault De La Longrais, R.C., and Grignolo, F.M. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23:752-763, 2003. (Pubitemid 38040573)
6. Yannuzzi, L.A., Slakter, J.S., Gross, N.E., et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy a pilot study. Retina 23:288-298, 2003. (Pubitemid 36792972)
7. Chan, W.-M., Lam, D.S.C, Lai, T.Y.Y, Tam, B.S.M, Liu, D.T.L, and Chan, C.K.M. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br. J. Ophthalmol. 87:1453-1458, 2003. (Pubitemid 38010546)
8. Colucciello, M. Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. Retina 26:239-242, 2006. (Pubitemid 44400737)
9. Wang, M.S.M, Sander, B., and Larsen, M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am. J. Ophthalmol. 133:787-793, 2002. (Pubitemid 34580626)
10. Wang, M., Munch, I.C., Hasler, P.W., Prunte, C., and Larsen, M. Central serous chorioretinopathy. Acta. Ophthalmol. 86:126-145, 2008.
11. Arevalo, J.F., Garcia-Amaris, R.A., Roca, J.A., et al. Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema Pilot study of the Pan-American Collaborative Retina Study Group. J. Cataract. Refract. Surg. 33:2098-2105, 2007. (Pubitemid 350167520)
12. Iturralde, D., Spaide, R.F., Meyerle, C.B., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion a short-term study. Retina 26:279-284, 2006. (Pubitemid 44318180)
13. Kook, D., Wolf, A., Kreutzer, T., et al. Long-term effect of intravitreal bevacizumab (Avastin) in patients with chronic diffuse diabetic macular edema. Retina 28:1053-1060, 2008.
14. Oshima, Y., Sakaguchi, H., Gomi, F., and Tano, Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 142:155-158, 2006.
15. Grisanti, S., Biester, S., Peters, S., Tatar, O., Ziemssen, F., and Bartz-Schmidt, K.U. Intracameral bevacizumab for iris rubeosis. Am. J. Ophthalmol. 142:158-160, 2006. (Pubitemid 43946796)
16. 164 is proinflammatory in the diabetic retina. Invest. Ophthalmol. Vis. Sci. 44:2155-2162, 2003. (Pubitemid 36520312)
17. Torres-Soriano, M.E., Garcia-Aguirre, G., Kon-Jara, V., et al. A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (Case Reports). Graefes. Arch. Clin. Exp. Ophthalmol. 246:1235-1239, 2008.
18. Lim, S.J., Roh, M.I., and Kwon, O.W. Intravitreal bevacizumab injection for central serous chorioretinopathy. Retina 2010; 30:100-106.